Prostate cancer: Optimizing the duration of androgen deprivation therapy

Eric M. Horwitz

doi:10.1038/nrurol.2009.194

Prostate cancer: Optimizing the duration of androgen deprivation therapy

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	527-529
Number of pages	3
Journal	Nature Reviews Urology
Volume	6
Issue number	10
DOIs	https://doi.org/10.1038/nrurol.2009.194
State	Published - 2009

Keywords

Antineoplastic Agents, Hormonal/therapeutic use
Chemotherapy, Adjuvant
Humans
Male
Prostatic Neoplasms/drug therapy
Randomized Controlled Trials as Topic
Time Factors
Triptorelin Pamoate/therapeutic use

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrurol.2009.194

Cite this

@article{4949c93f30944707aaeeb236f96f4a58,

title = "Prostate cancer: Optimizing the duration of androgen deprivation therapy",

keywords = "Antineoplastic Agents, Hormonal/therapeutic use, Chemotherapy, Adjuvant, Humans, Male, Prostatic Neoplasms/drug therapy, Randomized Controlled Trials as Topic, Time Factors, Triptorelin Pamoate/therapeutic use",

author = "Horwitz, \{Eric M.\}",

year = "2009",

doi = "10.1038/nrurol.2009.194",

language = "English",

volume = "6",

pages = "527--529",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Research",

number = "10",

}

TY - JOUR

T1 - Prostate cancer

T2 - Optimizing the duration of androgen deprivation therapy

AU - Horwitz, Eric M.

PY - 2009

Y1 - 2009

KW - Antineoplastic Agents, Hormonal/therapeutic use

KW - Chemotherapy, Adjuvant

KW - Humans

KW - Male

KW - Prostatic Neoplasms/drug therapy

KW - Randomized Controlled Trials as Topic

KW - Time Factors

KW - Triptorelin Pamoate/therapeutic use

UR - https://www.scopus.com/pages/publications/70349964680

U2 - 10.1038/nrurol.2009.194

DO - 10.1038/nrurol.2009.194

M3 - Article

C2 - 19806170

SN - 1759-4812

VL - 6

SP - 527

EP - 529

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 10

ER -

Prostate cancer: Optimizing the duration of androgen deprivation therapy

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this